Amylin and GLP-1 combination or co-agonist
Cagrilintide and semaglutide 2.4/2.4 mg subcutaneous once weekly
CAGSEMA_SC_2p4_2p4MG_QW
- Agent
- cagrilintide and semaglutide
- Route
- SC
- Dose
- 2.4/2.4 mg
- Frequency
- QW
- Dosing
- fixed
- Mechanism
- Amylin analogue co-formulated with a GLP-1 receptor agonist (cagrilintide with semaglutide) or unimolecular amylin and GLP-1 agonist (amycretin)
- Trials
- 0
- Participants in these arms
- 0